To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5510 | Way-260022 |
Potent and Selective Inhibitor of the Norepinephrine Transporter
More description
|
|
| DCC5509 | Way-171230 |
Inhibitor of matrix metalloproteinase-1 (MMP-1)
More description
|
|
| DCC5508 | Way-170523 |
Potent and selective inhibitor of matrix metalloprotease MMP-13 (Collagenase-3)
More description
|
|
| DCC5507 | Way-151693 |
Inhibitor of human collagenase-3 (MMP-13)
More description
|
|
| DCC5506 | way-133537 |
ATP-sensitive potassium channel opener
More description
|
|
| DCC5505 | Way-123783 |
SGLT2 inhibitor
More description
|
|
| DCC5504 | Way103 |
Very late adhesion molecule 4 (VLA-4) antagonist, inhibiting VLA-4/VCAM-1 ligation as a means of modulating eosinophil functions beyond its action on cell adhesion and migration
More description
|
|
| DCC5503 | Wallichoside |
Nocel inhibitor of BMI1 promoter activity, decreasing BMI1 protein levels in HCT116 human colon carcinoma cells, significantly reducing levels of the CSC biomarker epithelial cell adhesion molecule and diminishing the self-renewal capability of CSCs
More description
|
|
| DCC5502 | waladin1 |
Mixed competitive/noncompetitive inhibitor of
More description
|
|
| DCC5501 | w-5 Hydrochloride |
Calmodulin antagonist, inhibiting Ca2+/calmodulin-regulated enzyme activities
More description
|
|
| DCC5499 | Vzmc013 |
Novel Probe of Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity
More description
|
|
| DCC5497 | Vuf8504 |
Allosteric modulator of A3 adenosine receptors
More description
|
|
| DCC5496 | Vuf-8430 |
Potent histamine H4 receptor full agonist
More description
|
|
| DCC5495 | Vuf-6884 |
Full agonist of hH4R with ~300-fold selectivity over hH3R and hH2R, but showing potent inverse agonistic activity at hH1R
More description
|
|
| DCC5494 | Vuf5834 |
Novel full inverse agonist at CXCR3 N3.35A
More description
|
|
| DCC5493 | vuf5455 |
Adenosine A3 receptor (A3AR) allosteric modulator
More description
|
|
| DCC5492 | Vuf5391 |
H3R inverse agonist
More description
|
|
| DCC5491 | vuf5228 |
Histamine H3 receptor antagonist
More description
|
|
| DCC5490 | Vuf16620 |
Novel photoswitchable modulator of the CXCR3 chemokine receptor
More description
|
|
| DCC5489 | Vuf16216 |
Novel CXCR3 ligand, photoswitching from antagonism to agonism
More description
|
|
| DCC5488 | Vuf15888 |
Novel photoswitchable modulator of the CXCR3 chemokine receptor
More description
|
|
| DCC5487 | Vuf15259 |
Novel inhibitor of Hbp secretion, activating σE stress, impairing Hbp secretion and decreasing the abundance of OMPs, consistent with impaired BAM function
More description
|
|
| DCC5486 | Vuf14862 |
Novel robust and fatigue-resistant photoswitchable GPCR antagonist
More description
|
|
| DCC5485 | Vuf14738 |
Novel robust and fatigue-resistant photoswitchable GPCR antagonist
More description
|
|
| DCC5484 | vuf14480 |
Partial agonist in hH 4 R-mediated G protein signalling and β-arrestin2 recruitment, bounding covalently to the hH4R
More description
|
|
| DCC5483 | Vuf11222 |
First reported nonpeptidomimetic agonist on The G protein-coupled chemokine receptor CXCR3
More description
|
|
| DCC5482 | Vuf11211 |
Potent CXCR3 Antagonist, extending from the minor pocket into the major pocket of the transmembrane domains and binding between residues in helices 1 (Y1.39), 2 (W2.60), 3 (F3.32), 4 (D4.60), 6 (Y6.51), and 7 (S7.39, Y7.43)
More description
|
|
| DCC5481 | Vuf10558 |
Highly Potent Human Histamine H4 Receptor Inverse Agonist
More description
|
|
| DCC5480 | Vuf10499 |
Potent human H4 receptor inverse agonist
More description
|
|
| DCC5478 | Vuf10166 Hydrochloride |
Novel potent ligand at 5-HT3A and 5-HT3AB receptors with different activities
More description
|
|